Rockwell Medical, Inc. (RMTI:NASDAQ) closed at $7.98 on October 15, 2026, up 3.64% on the day. The stock trades 38.1% below its 52-week high of $12.90 and 63.2% above its 52-week low of $4.89. Over the past year, it lost 32.9%. Rockwell Medical, Inc. is part of the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +5.42% | +2.31% | +26.67% | -15.11% | -32.94% |
In 252 trading sessions since October 15, 2025, RMTI closed higher on 105 days (42%). Its best day was January 20, 2026 (+31.25%) and its worst was March 26, 2026 (-9.62%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 3 times.
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease, iron deficiency, secondary hyperparathyroidism, and hemodialysis. The company's lead drug is Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment via dialysate. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and rep...
Find more stocks like RMTI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.